De Ruysscher Dirk, Houben Ans, Aerts Hugo J W L, Dehing Cary, Wanders Rinus, Ollers Michel, Dingemans Anne-Marie C, Hochstenbag Monique, Boersma Liesbeth, Borger Jacques, Dekker Andre, Lambin Philippe
Department of Radiation Oncology (Maastro clinic), Maastricht University Medical Center(+), Maastricht, The Netherlands.
Radiother Oncol. 2009 Jun;91(3):415-20. doi: 10.1016/j.radonc.2009.01.004. Epub 2009 Feb 3.
As Radiation-Induced Lung Toxicity (RILT) is dose-limiting for radiotherapy (RT) of lung cancer and current parameters are only moderately associated with RILT, we sought for novel parameters associated with RILT.
In this prospective study, FDG-PET-CT scans were taken on days 0, 7 and 14 after initiation of high-dose RT in 18 patients with stage III non-small cell lung cancer. The maximal Standardized Uptake Value (SUV(max)) in the lung outside of the GTV was used as a measure of FDG uptake. At the same time-points, the serum IL-6 concentrations were measured. RILT was defined as dyspnea score 2 (CTCAE3.0).
Six of 18 patients developed RILT. Before RT, SUV(max) in the lung was not significantly different between patients who developed RILT and those who did not develop RILT. Patients who developed RILT post-radiation had a significant increased SUV on days 7 and 14 during RT, whereas the group that did not experience RILT showed no significant SUV changes. The SUV(max) of the lungs increased significantly more in the group that later developed RILT compared to those who did not develop RILT. Neither the IL-6 concentration nor the mean lung dose was associated with RILT.
The increase in FDG uptake in the normal lung early during RT was highly associated with the subsequent development of clinical RILT. This may help to identify patients at high risk for RILT at a time when adjustments of the treatment or strategies to prevent RILT are still possible.
由于放射性肺损伤(RILT)是肺癌放疗(RT)的剂量限制因素,且目前的参数与RILT仅呈中度相关,我们寻找与RILT相关的新参数。
在这项前瞻性研究中,对18例III期非小细胞肺癌患者在高剂量放疗开始后的第0、7和14天进行了FDG-PET-CT扫描。GTV外肺组织的最大标准化摄取值(SUV(max))用作FDG摄取的指标。在相同时间点,测量血清IL-6浓度。RILT定义为呼吸困难评分为2(CTCAE3.0)。
18例患者中有6例发生了RILT。放疗前,发生RILT的患者与未发生RILT的患者肺内SUV(max)无显著差异。放疗后发生RILT的患者在放疗期间第7天和第14天SUV显著升高,而未发生RILT的组SUV无显著变化。与未发生RILT的组相比,后来发生RILT的组肺内SUV(max)升高更为显著。IL-6浓度和平均肺剂量均与RILT无关。
放疗早期正常肺组织FDG摄取增加与随后临床RILT的发生高度相关。这可能有助于在仍有可能调整治疗或采取预防RILT策略时识别RILT高危患者。